YU44649B - Process for obtaining crystalline cephadroxyl monohydrate - Google Patents

Process for obtaining crystalline cephadroxyl monohydrate

Info

Publication number
YU44649B
YU44649B YU2427/87A YU242787A YU44649B YU 44649 B YU44649 B YU 44649B YU 2427/87 A YU2427/87 A YU 2427/87A YU 242787 A YU242787 A YU 242787A YU 44649 B YU44649 B YU 44649B
Authority
YU
Yugoslavia
Prior art keywords
cefadroxil
monohydrate
obtaining crystalline
crystalline
cephadroxyl
Prior art date
Application number
YU2427/87A
Other languages
English (en)
Other versions
YU242787A (en
Inventor
L Marsili
Original Assignee
Rifar Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rifar Sarl filed Critical Rifar Sarl
Publication of YU242787A publication Critical patent/YU242787A/xx
Publication of YU44649B publication Critical patent/YU44649B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU2427/87A 1987-08-03 1987-12-29 Process for obtaining crystalline cephadroxyl monohydrate YU44649B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/080,999 US4898938A (en) 1987-08-03 1987-08-03 Method for preparing crystalline cefadroxil monohydrate

Publications (2)

Publication Number Publication Date
YU242787A YU242787A (en) 1989-02-28
YU44649B true YU44649B (en) 1990-10-31

Family

ID=22161022

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2427/87A YU44649B (en) 1987-08-03 1987-12-29 Process for obtaining crystalline cephadroxyl monohydrate

Country Status (18)

Country Link
US (1) US4898938A (xx)
EP (1) EP0302145B1 (xx)
JP (1) JP2655664B2 (xx)
KR (1) KR960002910B1 (xx)
CN (1) CN1016607B (xx)
AT (1) ATE105560T1 (xx)
AU (1) AU597136B2 (xx)
CA (1) CA1285554C (xx)
DE (1) DE3789810T2 (xx)
DK (1) DK680387A (xx)
ES (1) ES2056059T3 (xx)
FI (1) FI88043C (xx)
NO (1) NO168425C (xx)
PH (1) PH23648A (xx)
PT (1) PT86526B (xx)
RU (1) RU1804461C (xx)
YU (1) YU44649B (xx)
ZA (1) ZA879701B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0433428B1 (en) * 1989-07-10 1994-10-12 Chemferm V.O.F. A stable form of cephradine, process for its production and intermediates used therein
IT1251999B (it) * 1991-11-11 1995-05-27 Opos Biochimica Srl Forma cristallina di un antibiotico cefalosporinico
US5589593A (en) * 1991-11-11 1996-12-31 Biochimica Opos Spa Crystalline form of a cephalosporin antibiotic
JP2005530746A (ja) * 2002-05-03 2005-10-13 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロールファーマソルブ溶媒和物
US20040077849A1 (en) * 2002-10-16 2004-04-22 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefadroxil
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
CN1311830C (zh) * 2004-02-27 2007-04-25 石药集团中奇制药技术（石家庄）有限公司 头孢羟氨苄口腔崩解片及其制备方法
WO2007134987A1 (en) * 2006-05-19 2007-11-29 Dsm Ip Assets B.V. Process for the crystallisation of cefadroxil
CN102134250B (zh) * 2011-01-19 2013-03-13 天津大学 一种头孢羟氨苄单水合物的结晶方法及结晶
CN104447795B (zh) * 2014-11-28 2016-08-17 珠海金鸿药业股份有限公司 一种头孢羟氨苄化合物及其药物组合物
CN105534937B (zh) * 2015-12-30 2019-12-03 石药集团欧意药业有限公司 一种头孢羟氨苄片剂及其制备方法
CN106588953B (zh) * 2016-11-08 2018-11-27 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物头孢羟氨苄晶型化合物及其组合物
CN106588954B (zh) * 2016-11-08 2018-11-27 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物羟氨苄晶体化合物及其组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
GB8714180D0 (en) * 1987-06-17 1987-07-22 Rifar Srl Anhydrous crystalline cefadroxil
AU1628588A (en) * 1987-04-24 1988-12-02 Invenmark Limited Puzzle

Also Published As

Publication number Publication date
KR960002910B1 (ko) 1996-02-28
JPS6442487A (en) 1989-02-14
NO880026D0 (no) 1988-01-05
EP0302145A2 (en) 1989-02-08
JP2655664B2 (ja) 1997-09-24
EP0302145A3 (en) 1989-08-23
PH23648A (en) 1989-09-27
DK680387D0 (da) 1987-12-22
YU242787A (en) 1989-02-28
FI88043C (fi) 1993-03-25
CN1016607B (zh) 1992-05-13
DK680387A (da) 1989-02-04
ZA879701B (en) 1988-06-23
PT86526B (pt) 1994-10-31
KR890003775A (ko) 1989-04-18
DE3789810T2 (de) 1994-08-18
AU8304587A (en) 1989-02-09
DE3789810D1 (de) 1994-06-16
PT86526A (pt) 1989-09-14
FI88043B (fi) 1992-12-15
CA1285554C (en) 1991-07-02
NO168425C (no) 1992-02-19
AU597136B2 (en) 1990-05-24
FI881040A (fi) 1989-02-04
EP0302145B1 (en) 1994-05-11
RU1804461C (ru) 1993-03-23
US4898938A (en) 1990-02-06
ATE105560T1 (de) 1994-05-15
ES2056059T3 (es) 1994-10-01
NO880026L (no) 1989-02-06
FI881040A0 (fi) 1988-03-07
CN1031085A (zh) 1989-02-15
NO168425B (no) 1991-11-11

Similar Documents

Publication Publication Date Title
YU242787A (en) Process for obtaining crystalline cephadroxyl monohydrate
PL238405A1 (en) Process for preparing novel derivatives of 2-aminocarboxylic acid
DE3272660D1 (en) New beta-lactam acetic acid derivatives, the process for preparing them, and their use as intermediates for 1-azabicyclo(3.2.0.)hept-2-ene antibiotics
EP0287751A3 (en) Novel crystalline cefadroxil and method for producing it
EP0295333A3 (en) Substantially anhydrous crystalline cefadroxil and method for producing it
PL238177A1 (en) Process for preparing derivatives of /1,2,3-de//1,4/-benzoxazin-6-carboxylic acid
PL244763A1 (en) Process for preparing novel dioxide derivatives of 4- hydroxy-2-methyl-2h-1,2-benzothiazine
YU188581A (en) Process for obtaining 7-amino-cephalosporanic acid derivatives
DE3271921D1 (en) Process for the preparation of imidazoledicarboxylic acid derivatives of cephalosporins
EG18418A (en) Process for the preparation of novel 2-thienyloxacetic acid derivatives
HUT37917A (en) Process for production of derivatives of n-iodineproporgilchlor-methan-sulphonamid and microbic preparatives continig teherof as reagent